CIK 0001662579
- Non-accelerated filer
- Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 475617627
- Phone
- +1 617-231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- 4 Grant or award Director acquired 194 shares (grant or award)
- 4 Open-market sale Chief Medical Officer sold 15,000 shares at an average $45.43 ($681,438)
- 4 Open-market sale Director sold 1,850 shares at an average $50.04 ($92,573)
- 4 Open-market sale Director sold 32,743 shares at an average $50.28 ($1,646,251)
- 4 Open-market sale Director sold 21,161 shares at an average $50.09 ($1,059,956)
- 4 Open-market sale Director sold 755 shares at $49.89 ($37,667)
- 4 Open-market sale Director sold 81,676 shares at an average $48.78 ($3,984,396)
- 4 Open-market sale Director sold 9,210 shares at an average $50.05 ($460,985)
- 4 Open-market sale Chief Legal Officer sold 12,500 shares at $50.00 ($625,000)
- 4 Open-market sale Director sold 755 shares at $40.73 ($30,751)
- 4 Grant or award Director acquired 157 shares (grant or award)
- 4 Open-market sale Director sold 14,407 shares at $45.16 ($650,587)
- 4 Open-market sale Chief Scientific Officer sold 17,057 shares at $45.01 ($767,812)
- 4 Open-market sale Chief Legal Officer sold 12,500 shares at $45.00 ($562,500)
- 4 Open-market sale Director sold 15,593 shares at an average $45.01 ($701,774)
- 4 Open-market sale Chief Scientific Officer sold 68,315 shares at an average $45.00 ($3,074,387)
- 4 Open-market sale Chief Medical Officer sold 15,000 shares at $45.00 ($675,000)
- 4 Open-market sale Director sold 755 shares at $37.37 ($28,214)
- 4 Grant or award Director acquired 522 shares (grant or award)
- 4 Grant or award Director acquired 251 shares (grant or award)
Page 12 of 15 · 296 filings